Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. (ZNTL) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 540 transactions totaling $244.3M, demonstrating a bearish sentiment with -$154.0K in net insider flow. The most recent transaction on Feb 10, 2026 involved a sale of 6,894 shares valued at $16.7K.
ZNTL Insider Activity Summary
Who Is Buying ZNTL Stock?
No significant insider buying has been recorded for ZNTL in the recent period.
Who Is Selling ZNTL Stock?
No significant insider selling has been recorded for ZNTL in the recent period.
Is Zentalis Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ZNTL is bearish with an Insider Alignment Score of 50/100 and a net flow of -$154.0K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ZNTL Frequently Asked Questions
Understanding ZNTL Insider Activity
Insider trading at Zentalis Pharmaceuticals, Inc. (ZNTL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading ZNTL stock, having executed 540 transactions in the past 90 days. The most active insider is Capital Management Company, Lp Matrix (Executive), who has made 1 transactions totaling $107.9M.
Related Tools
Track Zentalis Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at ZNTL file new Form 4 transactions